Bartosz Wasag
Overview
Explore the profile of Bartosz Wasag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mysliwiec M, Bandura M, Woloszyn-Durkiewicz A, Hennig M, Walczak M, Peregud-Pogorzelski J, et al.
Arch Med Sci
. 2025 Feb;
20(6):1741-1753.
PMID: 39967943
Familial hypercholesterolemia (FH) is the most common monogenic disease leading to the accelerated development of atherosclerotic cardiovascular disease (ASCVD). Despite increasing medical knowledge, diagnostic testing, and a growing number of...
2.
Huminska-Lisowska K, Zielinska K, Mieszkowski J, Michalowska-Sawczyn M, Cieszczyk P, Labaj P, et al.
PLoS One
. 2024 Feb;
19(2):e0297858.
PMID: 38381714
The influence of human gut microbiota on health and disease is now commonly appreciated. Therefore, it is not surprising that microbiome research has found interest in the sports community, hoping...
3.
Remon J, Besse B, Aix S, Callejo A, Al-Rabi K, Bernabe R, et al.
J Clin Oncol
. 2024 Feb;
42(12):1350-1356.
PMID: 38324744
JCO Osimertinib has been established as a standard of care for patients with common sensitizing -mutant advanced non-small-cell lung cancer (NSCLC) although the sequential approach (first-generation inhibitor gefitinib followed by...
4.
Butyrylcholinesterase signal sequence self-aggregates and enhances amyloid fibril formation in vitro
Jasiecki J, Targonska M, Janaszak-Jasiecka A, Kalinowski L, Waleron K, Wasag B
Chem Biol Interact
. 2023 Oct;
386:110783.
PMID: 37884182
Alzheimer's disease (AD) pathogenesis has been attributed to extracellular aggregates of amyloid β (Aβ) plaques and neurofibrillary tangles in the human brain. It has been reported that butyrylcholinesterase (BChE) also...
5.
Galaska R, Kulawiak-Galaska D, Dorniak K, Strozyk A, Sabisz A, Chmara M, et al.
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685656
We aimed to compare the extent of subclinical atherosclerosis in the ascending and descending aortas by measuring wall area and thickness using 3D cardiovascular magnetic resonance imaging (aAWAI and dAWAI)...
6.
Sobieralski P, Wasag B, Leszczynska A, Zuk M, Bieniaszewska M
Front Oncol
. 2023 Sep;
13:1224590.
PMID: 37671053
Introduction: Polycythemia vera (PV) and essential thrombocythemia (ET) are diseases driven by canonical mutations in JAK2, CALR, or MPL gene. Previous studies revealed that in addition to driver mutations, patients...
7.
Jasiecki J, Targonska M, Janaszak-Jasiecka A, Chmara M, Zuk M, Kalinowski L, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511194
Familial hypercholesterolemia (FH) is an autosomal-dominant disorder caused mainly by substitutions in the low-density lipoprotein receptor () gene, leading to an increased risk of premature cardiovascular diseases. Tremendous advances in...
8.
Jasiak A, Koczkowska M, Stukan M, Wydra D, Biernat W, Izycka-Swieszewska E, et al.
Exp Mol Pathol
. 2023 Feb;
130:104856.
PMID: 36791903
Background: The mRNA splicing is regulated on multiple levels, resulting in the proper distribution of genes' transcripts in each cell and maintaining cell homeostasis. At the same time, the expression...
9.
Racis M, Stanislawska-Sachadyn A, Sobiczewski W, Wirtwein M, Krzeminski M, Rynkiewicz A, et al.
J Appl Genet
. 2023 Jan;
64(2):319-327.
PMID: 36683124
Cardiovascular (CV) events are the number one cause of lifetime disability and deaths worldwide. It is well known that traditional risk factors do not fully correlate with clinical outcomes; therefore,...
10.
Nicos M, Harbers L, Patrucco E, Kramer-Drauberg M, Zhang X, Voena C, et al.
JTO Clin Res Rep
. 2022 Dec;
3(12):100435.
PMID: 36561283
Introduction: Brain metastases (BM) severely affect the prognosis and quality of life of patients with NSCLC. Recently, molecularly targeted agents were found to have promising activity against BM in patients...